Literature DB >> 2908648

Control of human breast cancer by estrogen, growth factors, and oncogenes.

R B Dickson, M E Lippman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2908648     DOI: 10.1007/978-1-4613-1733-3_6

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


× No keyword cloud information.
  21 in total

Review 1.  SH2 domain-containing signaling proteins in human breast cancer.

Authors:  R J Daly
Journal:  Breast Cancer Res Treat       Date:  1995-04       Impact factor: 4.872

2.  XIAP inhibitor and antiestrogen embelin abrogates metastasis and augments apoptosis in estrogen receptor positive human breast adenocarcinoma cell line MCF-7.

Authors:  K R Sumalatha; G Abiramasundari; G K Chetan; T Divya; G Sudhandiran; M Sreepriya
Journal:  Mol Biol Rep       Date:  2014-01-04       Impact factor: 2.316

3.  Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1.

Authors:  G Flouriot; H Brand; S Denger; R Metivier; M Kos; G Reid; V Sonntag-Buck; F Gannon
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

Review 4.  Growth factor and sex steroid interactions in breast cancer.

Authors:  N J Kenney; R B Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

Review 5.  Studies of human breast cancer metastasis using nude mice.

Authors:  J E Price; R D Zhang
Journal:  Cancer Metastasis Rev       Date:  1990-02       Impact factor: 9.264

6.  ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas.

Authors:  Lisa M J Lee; Jiang Cao; Hao Deng; Ping Chen; Zoran Gatalica; Zhao-Yi Wang
Journal:  Anticancer Res       Date:  2008 Jan-Feb       Impact factor: 2.480

7.  Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer.

Authors:  Joanna Szkandera; Gudrun Absenger; Nadia Dandachi; Peter Regitnig; Sigurd Lax; Michael Stotz; Hellmut Samonigg; Wilfried Renner; Armin Gerger
Journal:  Mol Genet Genomics       Date:  2012-08-18       Impact factor: 3.291

8.  Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development.

Authors:  W Ruan; C B Newman; D L Kleinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

Review 9.  William L. McGuire Memorial Symposium. Estrogen and progestin effects in human breast carcinogenesis.

Authors:  R J King
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical study.

Authors:  M Toi; T Tominaga; A Osaki; T Toge
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.